Home › Geographic Atrophy › Michigan
Geographic Atrophy clinical trials in Michigan
5 studies for Geographic Atrophy are looking for participants at sites in Michigan.
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Retina Associates of Michigan, Grand Blanc
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Foundation for Vision Research, Grand Rapids
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Sep 14, 2026 · NCT06635148Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- University of Michigan Kellogg Eye Center, Ann Arbor
- Associated Retinal Consultants, P.C., Royal Oak
- Associated Retinal Consultants, P.C., Traverse City
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- University of Michigan Kellog Eye Center, Ann Arbor
RecruitingPhase 1
Ages 50 and older · All sexes · Updated Sep 3, 2026 · NCT03178149Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Oakland Ophthalmic Surgery, Birmingham
Recruiting
Ages 65 and older · All sexes · Updated Dec 3, 2024 · NCT05438732From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.